Farmaci monodose: perchè no in Italia?
8 Jul 2025 · 1 min
0:43
In this short monologue, Massimiliano Dona highlights the contrast between the United States, where single‑dose (monodose) medication packs are common and include full legal labeling, and Italy, where such packs are rare. He explains that Italy’s lengthy authorization and traceability procedures, combined with pharmaceutical companies’ commercial interest in selling larger quantities, hinder the adoption of monodose packaging. He asks viewers whether they were aware of these differences, prompting reflection on waste, cost, and regulatory impact.
